Capricor Therapeutics
CAPR
#8779
Rank
HK$1.85 B
Marketcap
HK$32.09
Share price
-2.15%
Change (1 day)
-47.73%
Change (1 year)

Market capitalization of Capricor Therapeutics (CAPR)

Market cap: HK$1.85 Billion

As of August 2026 Capricor Therapeutics has a market cap of HK$1.85 Billion. This makes Capricor Therapeutics the world's 8779th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Capricor Therapeutics from 2002 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$1.85 B-84.79%
2025HK$12.21 B150.13%
2024HK$4.88 B315.26%
2023HK$1.17 B54.48%
2022HK$0.76 B37.77%
2021HK$0.55 B0.99%
2020HK$0.54 B949.97%
2019HK$52.11 M-48.29%
2018HK$0.10 B-68.25%
2017HK$0.31 B-28.1%
2016HK$0.44 B13.99%
2015HK$0.38 B13.72%
2014HK$0.34 B15.61%
2013HK$0.29 B1712.04%
2012HK$16.25 M-90.33%
2011HK$0.16 B0.6%
2010HK$0.16 B-34.25%
2009HK$0.25 B60.2%
2008HK$0.15 B-84.65%
2007HK$1.03 B4299.99%
2006HK$23.48 M-38.27%
2005HK$38.04 M-0.23%
2004HK$38.13 M27.78%
2003HK$29.84 M-63.79%
2002HK$82.43 M

End of Day market cap according to different sources

On Aug 9th, 2026 the market cap of Capricor Therapeutics was reported to be:

HK$1.85 Billion
by Nasdaq info icon info icon
HK$1.85 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$4.901 T 263,660.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$130.30 B 6,912.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
HK$81.75 B 4,299.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
HK$25.69 B 1,282.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
HK$0.10 B-94.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
HK$38.52 M-97.93%๐Ÿ‡บ๐Ÿ‡ธ USA